Table 2

Physical signs, laboratory results and medical treatment

eGFR≥90
n=5251
eGFR 60–89
n=18 240
eGFR 30–59
n=19 160
eGFR 15–29
n=4252
eGFR<15
n=813
p Value
Physical signs
 Heart rate (n=36 087)72 (64–84)72 (63–83)72 (64–83)74 (64–84)76 (67–90)<0.001
 Blood pressure systolic (n=47 142)120 (110–140)128 (112–140)125 (110–140)124 (110–140)130 (110–150)<0.001
 Blood pressure diastolic(n=47 081)75 (68–80)74 (65–80)70 (61–80)70 (60–80)70 (60–80)<0.001
 BMI (n=23 540)27 (24–31)26 (23–30)26 (23–29)26 (23–29)26 (23–29)<0.001
ECG
 Non-sinus rhythm(n=47 701)29%45%54%52%42%<0.001
 Left bundle branch block (n=43 550)15%16%17%17%14%0.006
 QRS-width, msek (n=38 098)100 (90–116)102 (90–124)104 (90–128)104 (90–130)104 (92–128)<0.001
Lab
 Haemoglobin (n=47 705)139 (127–150)135 (123–147)129 (117–141)120 (110–131)112 (103–123)<0.001
 Creatinine (n=47 716)67 (58–75)83 (72–93)116 (102–133)191 (163–220)382 (325–492)<0.001
 Potassium (n=27 713)4,1 (3,8–4,4)4,1 (3,8–4,4)4,2 (3,9–4,6)4,2 (3,9–4,6)4,5 (4,0–5,0)<0.001
 NT-proBNP (n=13 859)1390 (494–3366)2320 (1090–4800)3800 (1780–7826)7880 (3357–16 862)21 000 (1260–35 000)<0.001
Medication
 ACEI(n=47 701)76%69%58%38%20%<0.001
 >50% of target dose (n=29 412)80%77%72%55%49%<0.001
 ARB (n=47 694)16%29%22%20%16%<0.001
 >50% of target dose (n=9529)63%56%46%29%36%<0.001
 β-blocker (n=47 700)88%85%84%81%77%<0.001
 >50% of target dose (n=40 033)66%64%62%59%58%<0.001
 Aldosteronblocker (n=47 701)28%29%30%22%11%<0.001
 Digitalis(n=47 700)16%19%17%10%5%<0.001
 Statins (n=47 701)44%44%42%37%35%<0.001
 Nitrates (n=47 700)6%13%21%27%25%<0.001
 Anticoagulant (n=47 701)33%39%38%29%17%<0.001
 Aspirin (n=47 700)45%49%52%56%57%<0.001
  • Values are proportion or median and IQR.

  • ARB, angiotensin-receptor blocker; BMI, body mass index; eGRF, estimated glomerular filtration rate; NT-proBNP, N-terminal pro-brain natriuretic peptide.